Nebulized wet aerosol treatment in emergency department - Is it essential? Comparison with large spacer device for metered-dose inhaler

Chest

Volumn 112, Issue 6, 1997, Pages 1501-1505

  Mandelberg, Avigdor ^a   Priel, Israel E ^a   Chen, Erez ^a   Noviski, Natan ^a  

^a Department of Pulmonary Medicine ^*  (Israel)

Author keywords

Aerosol; Asthma; COPD; Emergency medicine; Intervention; MDI; Nebulization; Spacer device

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; PLACEBO; SALBUTAMOL; SODIUM CHLORIDE;

ADULT; AEROSOL; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EMERGENCY TREATMENT; HEADACHE; HEART PALPITATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; NEBULIZER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; TREATMENT OUTCOME; TREMOR;

EID: 0031441312     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.6.1501     Document Type: Article

References (2)

1. International consensus report on diagnosis and treatment of asthma. Bethesda, Md: National Heart, Lung and Blood Institute, National Institute of Health; publication No. 92-3091; June 1992
2. Turner JR, Corkery KJ, Eckman D, et al. Equivalence of continuous flow nebulizer and metered-dose inhaler with a reservoir for treatment of acute airflow obstruction. Chest 1988; 93:476-81